Formulations of oxabicycloheptanes and oxabicycloheptenes Grant US-11931354-B2 United States of America 19 Mar 2024
Combination therapy with notch and PD-1 or PD-L1 inhibitors Grant US-11826317-B2 United States of America 28 Nov 2023
HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic… Grant US-11813261-B2 United States of America 14 Nov 2023
MEK1 mutation conferring resistance to RAF and MEK inhibitors Grant US-11789022-B2 United States of America 17 Oct 2023
Gold particles including an oleo-gum resin and/or a derivative thereof and methods of… Grant US-11752108-B2 United States of America 12 Sep 2023
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a BCL-2… Grant US-11666568-B2 United States of America 06 Jun 2023
Ion generation using modified wetted porous materials Grant US-11635415-B2 United States of America 25 Apr 2023
Methylphenidate extended release chewable tablet Grant US-11633389-B2 United States of America 25 Apr 2023
Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer Grant US-11564929-B2 United States of America 31 Jan 2023
Methods of use and pharmaceutical combinations comprising histone deacetylase inhibitors… Grant US-11433069-B2 United States of America 06 Sep 2022
Compounds, compositions and methods for treating or preventing HER-driven drug-resistant… Grant US-11426409-B2 United States of America 30 Aug 2022
Methods of treating a neurodegenerative disease in a mammal in need thereof Grant US-11369596-B2 United States of America 28 Jun 2022
Uses of myostatin antagonists, combinations containing them and uses thereof Grant US-11357851-B2 United States of America 14 Jun 2022
Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer Grant US-11298362-B2 United States of America 12 Apr 2022
Combinations and methods comprising a capsid assembly inhibitor Grant US-11129834-B2 United States of America 28 Sep 2021
Ion generation using modified wetted porous materials Grant US-11119081-B2 United States of America 14 Sep 2021
Methylphenidate extended release chewable tablet Grant US-11103494-B2 United States of America 31 Aug 2021
Methylphenidate extended release chewable tablet Grant US-11103495-B2 United States of America 31 Aug 2021
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication Grant US-11014941-B2 United States of America 25 May 2021
Methylphenidate extended release chewable tablet Grant US-10857143-B2 United States of America 08 Dec 2020
Antibacterial compounds and methods of making and using same Grant US-10829440-B2 United States of America 10 Nov 2020
MEK1 mutation conferring resistance to RAF and MEK inhibitors Grant US-10788496-B2 United States of America 29 Sep 2020
Ion generation using modified wetted porous materials Grant US-10732159-B2 United States of America 04 Aug 2020
Combination therapy with Notch and PD-1 or PD-L1 inhibitors Grant US-10688104-B2 United States of America 23 Jun 2020
7-dehydrocholesterol derivatives and methods using same Grant US-10683324-B2 United States of America 16 Jun 2020
Syringolin analogues and methods of making and using same Grant US-10597368-B2 United States of America 24 Mar 2020
Methylphenidate extended release chewable tablet Grant US-10507203-B2 United States of America 17 Dec 2019
Mannose derivatives for treating bacterial infections Application US-10407414-B2 United States of America 10 Sep 2019
Probes, systems, cartridges, and methods of use thereof Grant US-10381209-B2 United States of America 13 Aug 2019
Methods of treating a neurodegenerative disease in a mammal in need thereof Application US-10258615-B2 United States of America 16 Apr 2019
Zero voltage mass spectrometry probes and systems Grant US-10256085-B2 United States of America 09 Apr 2019
Modified release formulations containing drug-ion exchange resin complexes Grant US-10086087-B2 United States of America 02 Oct 2018
Methods of preventing neurodegeneration of association cortex in a mammal Application US-10022341-B2 United States of America 17 Jul 2018
Benzothiophene derivatives as estrogen receptor inhibitors Grant US-9988376-B2 United States of America 05 Jun 2018
Combinations of histone deacetylase inhibitors and immunomodulatory drugs Grant US-9949972-B2 United States of America 24 Apr 2018
MEK1 mutation conferring resistance to RAF and MEK inhibitors Grant US-9880169-B2 United States of America 30 Jan 2018
Methylphenidate extended release chewable tablet Grant US-9844544-B2 United States of America 19 Dec 2017
Methylphenidate extended release chewable tablet Grant US-9844545-B2 United States of America 19 Dec 2017
Ion generation using modified wetted porous materials Grant US-9797872-B2 United States of America 24 Oct 2017
Method for blocking HIV entry into dendritic cells by inhibiting sialoadhesin-sialyllactose… Grant US-9789130-B2 United States of America 17 Oct 2017
Ion generation using modified wetted porous materials Grant US-9230792-B2 United States of America 05 Jan 2016
Ion generation using modified wetted porous materials Grant US-8895918-B2 United States of America 25 Nov 2014
Nitric oxide-releasing medical devices Application US-7425218-B2 United States of America 16 Sep 2008
Nitric oxide-releasing 1-[(2-carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolates and… Application US-6379660-B1 United States of America 30 Apr 2002
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions… Grant US-6200558-B1 United States of America 13 Mar 2001
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions… Application US-6110453-A United States of America 29 Aug 2000
Use of nitric oxide-releasing agents to treat impotency Grant US-5910316-A United States of America 08 Jun 1999
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents Grant US-5814666-A United States of America 29 Sep 1998
Anti-hypertension compositions of secondary amine-nitric oxide adducts and use thereof Grant US-5731305-A United States of America 24 Mar 1998
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions… Grant US-5718892-A United States of America 17 Feb 1998
Selective prevention of organ injury in sepsis and shock using selection release of… Grant US-5714511-A United States of America 03 Feb 1998
Polysaccharide-bound nitric oxide-nucleophile adducts Grant US-5691423-A United States of America 25 Nov 1997
Implants, prostheses, and stents comprising polymer-bound nitric oxide/nucleophile… Grant US-5676963-A United States of America 14 Oct 1997
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions… Application US-5525357-A United States of America 11 Jun 1996
Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor… Grant US-5366997-A United States of America 22 Nov 1994